Order Article Reprints

Meurisse M, Catteau L, van Loenhout JAF, Braeye T, De Mot L, Serrien B, Blot K, Cauët E, Van Oyen H, Cuypers L, et al. Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium. Vaccines. 2023; 11(2):378. https://doi.org/10.3390/vaccines11020378

Meurisse, Marjan, Lucy Catteau, Joris A. F. van Loenhout, Toon Braeye, Laurane De Mot, Ben Serrien, Koen Blot, Emilie Cauët, Herman Van Oyen, Lize Cuypers, and et al. 2023. "Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium" Vaccines 11, no. 2: 378. https://doi.org/10.3390/vaccines11020378

Meurisse, M., Catteau, L., van Loenhout, J. A. F., Braeye, T., De Mot, L., Serrien, B., Blot, K., Cauët, E., Van Oyen, H., Cuypers, L., Belgian Collaborative Group on COVID-19 Hospital Surveillance, COVID-19 Genomics Belgium Consortium, Robert, A., & Van Goethem, N. (2023). Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium. Vaccines, 11(2), 378. https://doi.org/10.3390/vaccines11020378